Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 124.30
+4.46 (3.72%)
Jul 10, 2026, 3:00 PM CST
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 10.94 billion as of July 10, 2026. Its market cap has decreased by -17.59% in one year.
Market Cap
10.94B
Enterprise Value
9.89B
Revenue
427.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
124.30
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 10.94B, an increase of 148.02%. That is a compound annual growth rate of 14.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 10.94B | -24.01% |
| Dec 31, 2025 | 14.39B | 159.78% |
| Dec 31, 2024 | 5.54B | 50.94% |
| Dec 29, 2023 | 3.67B | -34.53% |
| Dec 30, 2022 | 5.61B | -22.40% |
| Dec 31, 2021 | 7.22B | 197.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 12.96B |
| Staidson (Beijing) BioPharmaceuticals | 11.57B |
| Shanghai Medicilon | 11.44B |
| Inner Mongolia Furui Medical Science | 11.42B |
| Tibet Cheezheng Tibetan Medicine | 11.36B |
| Chengzhi | 10.63B |
| GemPharmatech | 10.41B |
| Hualan Biological Vaccine | 10.06B |